Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Arcutis Biotherapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 239
- +14 vs. Q2 2025
- Shares held
- 125.8M
- −1.06M (−0.8%) vs. Q2 2025
- Total value
- $2.37B
- +$592.2M (+33.3%) vs. Q2 2025
- New holders
- 34
- 88 more added
- Sold out
- 20
- 83 more reduced
5 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| StemPoint Capital LP | 411,893 | $7.76M | 1.57% | +206,221+100.3% | Added |
| AQR Capital Management LLC | 441,315 | $8.32M | 0.01% | +66,082+17.6% | Added |
| MYDA Advisors LLC | 470,000 | $8.86M | 2.66% | +100,000+27.0% | Added |
| Tejara Capital Ltd | 520,503 | $9.81M | 5.38% | −352,878−40.4% | Reduced |
| Fishman Jay A Ltd | 565,650 | $10.7M | 0.91% | +9,500+1.7% | Added |
| Jupiter Asset Management Ltd | 659,331 | $12.4M | 0.11% | +246,593+59.7% | Added |
| Standard Life Aberdeen plc | 675,034 | $12.7M | 0.02% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 759,573 | $14.3M | 0.03% | +22,204+3.0% | Added |
| Cormorant Asset Management, LP | 775,000 | $14.6M | 1.01% | −225,000−22.5% | Reduced |
| Candriam Luxembourg S.C.A. | 778,044 | $14.7M | 0.08% | −12,391−1.6% | Reduced |
| Qube Research & Technologies Ltd | 814,567 | $15.4M | 0.02% | +237,074+41.1% | Added |
| Voloridge Investment Management, LLC | 833,490 | $15.7M | 0.05% | +833,490 | New |
| Bank of America Corp | 889,285 | $16.8M | 0.00% | −313,228−26.0% | Reduced |
| Northern Trust Corp | 940,202 | $17.7M | 0.00% | +11,514+1.2% | Added |
| Charles Schwab Investment Management Inc | 999,434 | $18.8M | 0.00% | +34,368+3.6% | Added |
| Driehaus Capital Management LLC | 1,097,004 | $20.7M | 0.15% | +11,050+1.0% | Added |
| GW&K Investment Management, LLC | 1,172,041 | $22.1M | 0.20% | −206,391−15.0% | Reduced |
| Nuveen, LLC | 1,370,356 | $25.8M | 0.01% | +604,777+79.0% | Added |
| American Century Companies Inc | 1,662,470 | $31.3M | 0.02% | −61,837−3.6% | Reduced |
| Goldman Sachs Group Inc | 1,804,988 | $34.0M | 0.00% | −85,258−4.5% | Reduced |
| Ensign Peak Advisors, Inc | 1,993,055 | $37.6M | 0.06% | −8,384−0.4% | Reduced |
| Perpetual Ltd | 2,024,606 | $38.2M | 0.47% | +1,998,086+7,534.3% | Added |
| D. E. Shaw & Co., Inc. | 2,118,713 | $39.9M | 0.03% | −44,288−2.0% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 2,120,508 | $40.0M | 23.11% | 00.0% | Unchanged |
| Franklin Resources Inc | 2,311,019 | $43.6M | 0.01% | −421,758−15.4% | Reduced |
| Janus Henderson Group PLC | 2,398,031 | $45.2M | 0.02% | +134,071+5.9% | Added |
| Geode Capital Management, LLC | 2,606,465 | $49.1M | 0.00% | +23,898+0.9% | Added |
| UBS Group AG | 2,948,438 | $55.6M | 0.01% | +10,499+0.4% | Added |
| Morgan Stanley | 4,276,394 | $80.6M | 0.00% | −38,136−0.9% | Reduced |
| Gilder Gagnon Howe & Co LLC | 4,429,108 | $83.5M | 0.85% | +273,345+6.6% | Added |
| State Street Corp | 4,641,315 | $87.5M | 0.00% | +114,378+2.5% | Added |
| Polar Capital Holdings Plc | 5,298,754 | $99.9M | 0.48% | +292,279+5.8% | Added |
| Vanguard Group Inc | 7,146,090 | $134.7M | 0.00% | +96,991+1.4% | Added |
| BlackRock, Inc. | 8,573,995 | $161.6M | 0.00% | +41,234+0.5% | Added |
| Frazier Life Sciences Management, L.P. | 9,874,511 | $186.1M | 5.58% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 10,478,000 | $197.5M | 5.99% | −1,057,582−9.2% | Reduced |
| Rubric Capital Management LP | 10,749,457 | $202.6M | 2.72% | 00.0% | Unchanged |
| Jennison Associates LLC | 12,254,119 | $231.0M | 0.13% | +1,144,714+10.3% | Added |
| Johnson Investment Counsel Inc | 1,600 | – | – | +1,600 | New |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,485,425−100.0% | Sold out |
| Royce & Associates LP | 0 | $0 | 0.00% | −374,540−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −200,253−100.0% | Sold out |
| Triumph Capital Management | 0 | $0 | 0.00% | −29,244−100.0% | Sold out |
| BCJ Capital Management, LLC | 0 | $0 | 0.00% | −24,970−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −24,008−100.0% | Sold out |
| Mach-1 Financial Group, Inc. | 0 | $0 | 0.00% | −22,254−100.0% | Sold out |
| Dauntless Investment Group, LLC | 0 | $0 | 0.00% | −16,951−100.0% | Sold out |
| Tocqueville Asset Management L.P. | 0 | $0 | 0.00% | −15,700−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −15,203−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −11,606−100.0% | Sold out |
| PEAK6 LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −10,057−100.0% | Sold out |
| Atlas Wealth LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −2,071−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −916−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −391−100.0% | Sold out |
| Legacy Wealth Managment, LLC | 0 | $0 | 0.00% | −360−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Norges Bank | – | – | – | – | Not filed |
| E Fund Management Co., Ltd. | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| First Horizon Advisors, Inc. | – | – | – | – | Not filed |
| Legacy Investment Solutions, LLC | – | – | – | – | Not filed |